Cargando…
How to Combine Diffusion-Weighted and T2-Weighted Imaging for MRI Assessment of Pathologic Complete Response to Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer?
OBJECTIVE: Adequate methods of combining T2-weighted imaging (T2WI) and diffusion-weighted imaging (DWI) to assess complete response (CR) to chemoradiotherapy (CRT) for rectal cancer are obscure. We aimed to determine an algorithm for combining T2WI and DWI to optimally suggest CR on MRI using visua...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Radiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390818/ https://www.ncbi.nlm.nih.gov/pubmed/34132075 http://dx.doi.org/10.3348/kjr.2020.1403 |
_version_ | 1783743149118586880 |
---|---|
author | Jang, Jong Keon Lee, Chul-min Park, Seong Ho Kim, Jong Hoon Kim, Jihun Lim, Seok-Byung Yu, Chang Sik Kim, Jin Cheon |
author_facet | Jang, Jong Keon Lee, Chul-min Park, Seong Ho Kim, Jong Hoon Kim, Jihun Lim, Seok-Byung Yu, Chang Sik Kim, Jin Cheon |
author_sort | Jang, Jong Keon |
collection | PubMed |
description | OBJECTIVE: Adequate methods of combining T2-weighted imaging (T2WI) and diffusion-weighted imaging (DWI) to assess complete response (CR) to chemoradiotherapy (CRT) for rectal cancer are obscure. We aimed to determine an algorithm for combining T2WI and DWI to optimally suggest CR on MRI using visual assessment. MATERIALS AND METHODS: We included 376 patients (male:female, 256:120; mean age ± standard deviation, 59.7 ± 11.1 years) who had undergone long-course CRT for rectal cancer and both pre- and post-CRT high-resolution rectal MRI during 2017–2018. Two experienced radiologists independently evaluated whether a tumor signal was absent, representing CR, on both post-CRT T2WI and DWI, and whether the pre-treatment DWI showed homogeneous hyperintensity throughout the lesion. Algorithms for combining T2WI and DWI were as follows: ‘AND,’ if both showed CR; ‘OR,’ if any one showed CR; and ‘conditional OR,’ if T2WI showed CR or DWI showed CR after the pre-treatment DWI showed homogeneous hyperintensity. Their efficacies for diagnosing pathologic CR (pCR) were determined in comparison with T2WI alone. RESULTS: Sixty-nine patients (18.4%) had pCR. AND had a lower sensitivity without statistical significance (vs. 62.3% [43/69]; 59.4% [41/69], p = 0.500) and a significantly higher specificity (vs. 87.0% [267/307]; 90.2% [277/307], p = 0.002) than those of T2WI. Both OR and conditional OR combinations resulted in a large increase in sensitivity (vs. 62.3% [43/69]; 81.2% [56/69], p < 0.001; and 73.9% [51/69], p = 0.008, respectively) and a large decrease in specificity (vs. 87.0% [267/307]; 57.0% [175/307], p < 0.001; and 69.1% [212/307], p < 0.001, respectively) as compared with T2WI, ultimately creating additional false interpretations of CR more frequently than additional identification of patients with pCR. CONCLUSION: AND combination of T2WI and DWI is an appropriate strategy for suggesting CR using visual assessment of MRI after CRT for rectal cancer. |
format | Online Article Text |
id | pubmed-8390818 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Korean Society of Radiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-83908182021-09-04 How to Combine Diffusion-Weighted and T2-Weighted Imaging for MRI Assessment of Pathologic Complete Response to Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer? Jang, Jong Keon Lee, Chul-min Park, Seong Ho Kim, Jong Hoon Kim, Jihun Lim, Seok-Byung Yu, Chang Sik Kim, Jin Cheon Korean J Radiol Gastrointestinal Imaging OBJECTIVE: Adequate methods of combining T2-weighted imaging (T2WI) and diffusion-weighted imaging (DWI) to assess complete response (CR) to chemoradiotherapy (CRT) for rectal cancer are obscure. We aimed to determine an algorithm for combining T2WI and DWI to optimally suggest CR on MRI using visual assessment. MATERIALS AND METHODS: We included 376 patients (male:female, 256:120; mean age ± standard deviation, 59.7 ± 11.1 years) who had undergone long-course CRT for rectal cancer and both pre- and post-CRT high-resolution rectal MRI during 2017–2018. Two experienced radiologists independently evaluated whether a tumor signal was absent, representing CR, on both post-CRT T2WI and DWI, and whether the pre-treatment DWI showed homogeneous hyperintensity throughout the lesion. Algorithms for combining T2WI and DWI were as follows: ‘AND,’ if both showed CR; ‘OR,’ if any one showed CR; and ‘conditional OR,’ if T2WI showed CR or DWI showed CR after the pre-treatment DWI showed homogeneous hyperintensity. Their efficacies for diagnosing pathologic CR (pCR) were determined in comparison with T2WI alone. RESULTS: Sixty-nine patients (18.4%) had pCR. AND had a lower sensitivity without statistical significance (vs. 62.3% [43/69]; 59.4% [41/69], p = 0.500) and a significantly higher specificity (vs. 87.0% [267/307]; 90.2% [277/307], p = 0.002) than those of T2WI. Both OR and conditional OR combinations resulted in a large increase in sensitivity (vs. 62.3% [43/69]; 81.2% [56/69], p < 0.001; and 73.9% [51/69], p = 0.008, respectively) and a large decrease in specificity (vs. 87.0% [267/307]; 57.0% [175/307], p < 0.001; and 69.1% [212/307], p < 0.001, respectively) as compared with T2WI, ultimately creating additional false interpretations of CR more frequently than additional identification of patients with pCR. CONCLUSION: AND combination of T2WI and DWI is an appropriate strategy for suggesting CR using visual assessment of MRI after CRT for rectal cancer. The Korean Society of Radiology 2021-09 2021-05-26 /pmc/articles/PMC8390818/ /pubmed/34132075 http://dx.doi.org/10.3348/kjr.2020.1403 Text en Copyright © 2021 The Korean Society of Radiology https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Gastrointestinal Imaging Jang, Jong Keon Lee, Chul-min Park, Seong Ho Kim, Jong Hoon Kim, Jihun Lim, Seok-Byung Yu, Chang Sik Kim, Jin Cheon How to Combine Diffusion-Weighted and T2-Weighted Imaging for MRI Assessment of Pathologic Complete Response to Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer? |
title | How to Combine Diffusion-Weighted and T2-Weighted Imaging for MRI Assessment of Pathologic Complete Response to Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer? |
title_full | How to Combine Diffusion-Weighted and T2-Weighted Imaging for MRI Assessment of Pathologic Complete Response to Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer? |
title_fullStr | How to Combine Diffusion-Weighted and T2-Weighted Imaging for MRI Assessment of Pathologic Complete Response to Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer? |
title_full_unstemmed | How to Combine Diffusion-Weighted and T2-Weighted Imaging for MRI Assessment of Pathologic Complete Response to Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer? |
title_short | How to Combine Diffusion-Weighted and T2-Weighted Imaging for MRI Assessment of Pathologic Complete Response to Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer? |
title_sort | how to combine diffusion-weighted and t2-weighted imaging for mri assessment of pathologic complete response to neoadjuvant chemoradiotherapy in patients with rectal cancer? |
topic | Gastrointestinal Imaging |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390818/ https://www.ncbi.nlm.nih.gov/pubmed/34132075 http://dx.doi.org/10.3348/kjr.2020.1403 |
work_keys_str_mv | AT jangjongkeon howtocombinediffusionweightedandt2weightedimagingformriassessmentofpathologiccompleteresponsetoneoadjuvantchemoradiotherapyinpatientswithrectalcancer AT leechulmin howtocombinediffusionweightedandt2weightedimagingformriassessmentofpathologiccompleteresponsetoneoadjuvantchemoradiotherapyinpatientswithrectalcancer AT parkseongho howtocombinediffusionweightedandt2weightedimagingformriassessmentofpathologiccompleteresponsetoneoadjuvantchemoradiotherapyinpatientswithrectalcancer AT kimjonghoon howtocombinediffusionweightedandt2weightedimagingformriassessmentofpathologiccompleteresponsetoneoadjuvantchemoradiotherapyinpatientswithrectalcancer AT kimjihun howtocombinediffusionweightedandt2weightedimagingformriassessmentofpathologiccompleteresponsetoneoadjuvantchemoradiotherapyinpatientswithrectalcancer AT limseokbyung howtocombinediffusionweightedandt2weightedimagingformriassessmentofpathologiccompleteresponsetoneoadjuvantchemoradiotherapyinpatientswithrectalcancer AT yuchangsik howtocombinediffusionweightedandt2weightedimagingformriassessmentofpathologiccompleteresponsetoneoadjuvantchemoradiotherapyinpatientswithrectalcancer AT kimjincheon howtocombinediffusionweightedandt2weightedimagingformriassessmentofpathologiccompleteresponsetoneoadjuvantchemoradiotherapyinpatientswithrectalcancer |